Condition: Open Angle Glaucoma (OAG) · Sponsor: Barnet Dulaney Perkins Eye Centers
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
This description comes directly from the study's public registry record.
Derek J Arnson, Master of Education · 4804201005 · derek.arnson@researchavp.com
Christine Funke, Medical Doctor · 4804201005 · christine.funke@BDPEC.com
Always discuss trial participation with your own doctor first.
| Barnet Dulaney Perkins Eye Centers | Mesa, Arizona, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06933836